drugset / Trial / NCT01993849
Use of N-Acetylcysteine (NAC) in Fingernail Biting
RandomizedParallel-groupDouble-blindTreatment
Summary
To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC) in onychophagia, preliminarily assessing the tolerability and effects of this pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will help decrease fingernail biting.
Timeline
- Start
- 2013-10
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 1200 mg | Oral |